ImmuneWatch

Exhibitor

ImmuneWatch is an immunoinformatics company focused on the analysis of antigen-specific T cell responses. We are a university spin-off founded in 2021, headquartered in Antwerp, Belgium. Our solutions support the design, development, and clinical translation of vaccines and immunotherapies for which T cell responses play a crucial role. We work with biopharma and academic researchers around the world to provide tailored, data-driven insights in clinical immune responses.

The T cell receptor (TCR) repertoire holds huge amounts of information on past, present and future immune responses of an individual. Decoding this information is crucial for understanding T cell responses in the context of cancer, infectious diseases and autoimmune diseases. ImmuneWatch’s extensive database and software can identify TCRs of clinical relevance and annotate the epitope specificity of TCR sequences, turning TCR repertoires into clinically actionable data. Our areas of expertise and core applications are immune monitoring of T cell responses following vaccination or immunotherapy, TCR biomarker identification, T cell product characterisation, discovery of immunogenic antigens and epitopes (target deconvolution), and patient stratification.